In patients receiving tirzepatide, the downstream activation of GLP-1 and GIP receptor-mediated molecular pathways, especially in those with chronic pancreatitis, could increase the risk of developing pancreatic cancer [41]
Review article: Clinical manifestations and outcomes of chronic nitrous oxide misuse: A systematic review
In fact, Urick believes the role of side effects and achieved weight loss goals have been underestimated in efforts to uncover the cause of GLP-1 discontinuation
GCG (Glucagon): Acts to slow gastric emptying, making people feel full longer and contributing to reduced calorie consumption
2001 : 3: 111-114) and in the course of an increased metabolic requirement (Fasciani A., et al
Both can cause nausea, vomiting, or diarrhea